Hip Muscle Strength in FAI Versus Normal Controls
Muscle Strength in Femoroacetabular Impingement: A Comparative Study of Patients With FAI Versus Normal Controls
1 other identifier
observational
20
1 country
1
Brief Summary
Hip Muscle Strength in femoro-acetabular impingement participants versus normal controls. To investigate the hip muscle strength in a normal control group and compare this to patients who have a diagnosis of femoro-acetabular impingement (diagnosed clinically and with confirmed radiological features).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Apr 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 24, 2016
CompletedFirst Posted
Study publicly available on registry
March 3, 2016
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedMarch 3, 2016
February 1, 2016
1 year
February 24, 2016
February 28, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle Strength on Dynamometer
3 months
Secondary Outcomes (1)
Kinematics of the Hip - Range of Movement
3 months
Study Arms (2)
Control Arm Group
Participants aged 18-30, Male and Female (10 participants each). Control group must have normal range of movement and no evidence of femoro-acetabular impingement (FAI) on clinical examination (negative impingement test, no symptoms). Other exclusions for Control Group include previous surgery to hip joint/s, history of arthritis, family history of FAI, patients who have had symptoms of hip pain in the preceding 1 year or may have other conditions which may affect the hip joint or hip muscle strength including neurological conditions or muscular dystrophy.
FAI Arm Comparison Group
Participants aged 18-30, Male and Female (10 participants each). Participants with femoro-acetabular impingement as diagnosed clinically and on radiological imaging for the comparison group (MRI).
Eligibility Criteria
Control Arm Group - Medical Students who fit the inclusion criteria and are between ages of 18-30. FAI Comparison Group - Participants will be recruited from Young Adult Hip Clinic, meeting the defined inclusion criteria and also being between the ages of 18-30.
You may qualify if:
- Males and Females.
- Aged 18-30.
- Control group - Normal range of movement and no evidence of femoro-acetabular impingement on clinical examination (negative impingement test, no symptoms).
- Participants with femoro-acetabular impingement as diagnosed clinically and on radiological imaging for the comparison group (MRI).
You may not qualify if:
- Patients under the age of 18.
- Patients over the age of 30.
- Control group - evidence of underlying pathology affecting the hip, abnormal range of motion, evidence of femoro-acetabular impingement on clinical examination.
- Previous surgery of the hip joints.
- Medical history of arthritis (including rheumatoid and reactive).
- Family history of femoro-acetabular impingement (control arm participants).
- Patients who are currently experiencing or have experienced hip pain in the previous 1 year (control arm).
- Other conditions (e.g. neurological, muscular dystrophy etc) which may affect hip muscle strength.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Addenbrooke's Hospital
Cambridge, Cambridgeshire, CB2 0QQ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vikas Khanduja, MA, FRCS (Orth)
Consultant Trauma and Orthopaedic Surgeon - Principal Investigator
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 24, 2016
First Posted
March 3, 2016
Study Start
April 1, 2016
Primary Completion
April 1, 2017
Study Completion
August 1, 2017
Last Updated
March 3, 2016
Record last verified: 2016-02
Data Sharing
- IPD Sharing
- Will not share